Clinical Trials Directory

Trials / Completed

CompletedNCT06783907

Technological-based Personalized Care Intervention for Supporting Older People With Diabetes Mellitus

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
60 (actual)
Sponsor
Hong Kong Metropolitan University · Academic / Other
Sex
All
Age
60 Years
Healthy volunteers
Not accepted

Summary

The objectives of this project are (1) to develop a new model of DM management using non-invasive healthcare technology for continuous glucose monitoring; (2) to use health apps to give timely personalized care intervention for enhancing compliance rate of DM self-management; \& (3) to compare the DM management using non-invasive healthcare technology to traditional invasive blood glucose monitoring method. The proposed study will adopt a RCT with two treatment arms to clarify the effects of non-invasive blood glucose device on blood glucose monitoring. The two arms will be the non-invasive blood glucose monitoring (arm 1) and traditional self-monitoring (arm 2) as a control. A block randomisation and a single-blind design will be used. The inclusion criteria are (1) aged ≥ 60 years old; (2) patients diagnosed with Type II DM; (3) patients experienced hypo (histix \< 4.0 mmol/L) or hyperglycemia (histix ≥16.0 mmol/L); \& (iv) the Abbreviated Mental Test (AMT) ≥ 6. Participants fitting the inclusion criteria will be selected by convenience sampling. They will join a two-arm RCT and will be allocated into the intervention or control group in a 1:1 ratio. The primary outcomes will be the point of care test (POCT) of HbA1C level and the secondary outcomes will be the fasting blood glucose, total cholesterol, blood pressure, basic anthropometric measurement, breath and blood ketone and Diabetes Self-Care activities questionnaire. The outcome measurements will be recorded before the intervention (T0) and immediately after the 8-week intervention (T1). The required sample size would be 30 participants per group (with a ratio of 1:1) for testing the feasibility of the study.

Detailed description

Research aim 1\. This study will aim to develop a new model of DM management using non- invasive healthcare technology for continuous glucose monitoring. 2 To use health apps to give timely personalized care intervention for enhancing compliance rate of DM self-management. 3. To compare the DM management using non-invasive healthcare technology to traditional invasive blood glucose monitoring method. 4. To improve self-management skills, decrease hospital admissions, and save medical. Our DM project integrates personalized care intervention with a non-invasive continuous glucose monitoring (CGM) device for diabetes patients. The use of mHealth (Mobile health) ensures timely care without time or location constraints, while Just-in-Time Adaptive Intervention (JITAI) provides instant, personalized support. The painless, non-invasive CGM device offers an alternative to traditional finger-prick methods, improving compliance with self-management. This approach is particularly beneficial for patients who struggle with conventional monitoring and aims to enhance both patient outcomes and healthcare efficiency, especially for older people at high risk of hypo- or hyperglycemia.

Conditions

Interventions

TypeNameDescription
BEHAVIORALNon-invasive blood glucose monitoringNon-invasive wearable glucose monitoring device for capturing participants' blood glucose. The intervention will include: 1. Training for self-management of diabetes and phone consultation. 2. Follow-up through phone calls or WhatsApp for hypoglycaemic or hyperglycaemic events. 3. Personalized care guided by sensor data. The Investigator will monitor the health data from the device regularly. A mobile app will track and record compliance with blood glucose monitoring.
BEHAVIORALTraditional blood glucose monitoringTraditional blood glucose monitoring Participants will engage in traditional self-monitoring of blood glucose at home over the course of 8 weeks. They are recommended to check their blood glucose levels one to two times per week and record all results. This will allow for the collection of data using traditional monitoring methods.

Timeline

Start date
2023-12-01
Primary completion
2025-06-10
Completion
2025-06-10
First posted
2025-01-20
Last updated
2025-09-11

Locations

1 site across 1 country: Hong Kong

Source: ClinicalTrials.gov record NCT06783907. Inclusion in this directory is not an endorsement.